Colleen Hanlon - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Role
VP of Medical Affairs
Signature
/s/ Colleen Hanlon
Issuer symbol
BWAY
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:03:11 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hanlon Colleen VP of Medical Affairs 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL /s/ Colleen Hanlon 18 Mar 2026 0002119434

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BWAY Ordinary Shares 53,881 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 10,000 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This figure includes: (i) 20,381 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,000 ordinary shares vesting in equal quarterly installments until November 1, 2026, (b) RSUs to receive 2,500 ordinary shares vesting in equal quarterly installments until Mach 5, 2028 and (c) RSUs to receive 25,000 ordinary shares with 6,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
F3 Stock options were granted on March 5, 2024, with the remaining options to purchase 5,000 ordinary shares vesting in equal quarterly installments until March 5, 2028.
F4 The exercise price is NIS 11.17 per share